Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Sep;73(9):2982-6.
doi: 10.1073/pnas.73.9.2982.

Implications of cross inhibitory interactions of potential mediators of hormone and neurotransmitter action

Implications of cross inhibitory interactions of potential mediators of hormone and neurotransmitter action

E Van Cauter et al. Proc Natl Acad Sci U S A. 1976 Sep.

Abstract

Mediators of hormone and neurotransmitter action may exert negative control on the accumulation of one another (adenosine 3':5'-cyclic monophosphate, or conversely). A model in which one agonist stimulates the formation of two mediators which inhibit each other's accumulation has been simulated. Three types of agonist-receptor interaction, five mechanisms of inhibition, and three types of basal activity have been considered which lead to a set of 45 descriptions of the general cross inhibition model. For these submodels, pattern of the relation of agonist to mediator concentrations at steady state conditions have been defined. Some patterns are complex with mediator curves exhibiting extrema, one a maximum and the other a minimum. The complexity of the pattern depends on the submodel and on the degree of asymmetry between the parameters of each of the mediator pathways (e.g.,affinities for the agonist, strength of the inhibitions, etc.). This simple model can thus account for complex experimental results without requiring the postulation of elaborate molecular models of agonist-receptor interaction. The simulations presented emphasize the necessity of investigating a wide range of agonist concentrations.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1975 Mar 25;250(6):2080-4 - PubMed
    1. Circ Res. 1975 Jan;36(1):8-17 - PubMed
    1. Biochem Biophys Res Commun. 1975 Jan 20;62(2):168-75 - PubMed
    1. Proc Natl Acad Sci U S A. 1975 Jan;72(1):108-12 - PubMed
    1. Metabolism. 1975 Mar;24(3):311-9 - PubMed

MeSH terms

LinkOut - more resources